(Q48349608)
Statements
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults (English)
Papadopoulos KP
Garvin JH
Fetell M
Garrett TJ
Savage DG
Balmaceda C
Bruce J
Sisti M
Isaacson S
De LaPaz R
Hawks R
Bagiella E